Evidence map›Paper›PMID 24892712›Full record

ArticleThe Journal of clinical investigation2014

Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses.

Satoshi Okumura, Takayuki Fujita, Wenqian Cai, Meihua Jin, Iyuki Namekata, Yasumasa Mototani, Huiling Jin, Yoshiki Ohnuki, Yayoi Tsuneoka, Reiko Kurotani and 18 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Estrogen Regulates CaBiomolecules · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 6 institutions in 1 country.

Satoshi Okumura
Takayuki Fujita
Wenqian Cai
Meihua Jin
Iyuki Namekata
Yasumasa Mototani
Huiling Jin
Yoshiki Ohnuki
Yayoi Tsuneoka
Reiko Kurotani
Kenji Suita
Yuko Kawakami
Shogo Hamaguchi
Takaya Abe
Hiroshi Kiyonari
Takashi Tsunematsu
Yunzhe Bai
Sayaka Suzuki
Yuko Hidaka
Masanari Umemura
Yasuhiro Ichikawa
Utako Yokoyama
Motohiko Sato
Fumio Ishikawa
Hiroko Izumi-Nakaseko
Satomi Adachi-Akahane
Hikaru Tanaka
Yoshihiro Ishikawa
Yokohama City University · JPCardiovascular Institute Hospital · JPGenetic Resources Center · JPTsurumi University · JPAichi Medical University · JPToho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PKA phosphorylates multiple molecules involved in calcium (Ca2+) handling in cardiac myocytes and is considered to be the predominant regulator of β-adrenergic receptor-mediated enhancement of cardiac contractility; however, recent identification of exchange protein activated by cAMP (EPAC), which is independently activated by cAMP, has challenged this paradigm. Mice lacking Epac1 (Epac1 KO) exhibited decreased cardiac contractility with reduced phospholamban (PLN) phosphorylation at serine-16, the major PKA-mediated phosphorylation site. In Epac1 KO mice, intracellular Ca2+ storage and the magnitude of Ca2+ movement were decreased; however, PKA expression remained unchanged, and activation of PKA with isoproterenol improved cardiac contractility. In contrast, direct activation of EPAC in cardiomyocytes led to increased PLN phosphorylation at serine-16, which was dependent on PLC and PKCε. Importantly, Epac1 deletion protected the heart from various stresses, while Epac2 deletion was not protective. Compared with WT mice, aortic banding induced a similar degree of cardiac hypertrophy in Epac1 KO; however, lack of Epac1 prevented subsequent cardiac dysfunction as a result of decreased cardiac myocyte apoptosis and fibrosis. Similarly, Epac1 KO animals showed resistance to isoproterenol- and aging-induced cardiomyopathy and attenuation of arrhythmogenic activity. These data support Epac1 as an important regulator of PKA-independent PLN phosphorylation and indicate that Epac1 regulates cardiac responsiveness to various stresses.

Indexed as

AnimalsCalcium-Binding ProteinsCalcium SignalingCyclic AMP-Dependent Protein KinasesFemaleGuanine Nucleotide Exchange FactorsMaleMiceMice, Inbred C57BLMice, Inbred CBAMice, KnockoutMyocardial ContractionMyocardiumMyocytes, CardiacPhospholambanPhosphorylationCalcium-Binding ProteinsCyclic AMP-Dependent Protein KinasesEpac protein, mouseGuanine Nucleotide Exchange FactorsPhospholamban

Identifiers

PMID24892712
PMCPMC4038559
OpenAlexW1996382576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.